SWOG clinical trial number
CTSU/EA8153

Cabazitaxel with Abiraterone Versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial

Open
Phase
II
Abbreviated Title
Rando Exten Dis Cabazitaxel w/ Abi vs. Abi following Docetaxel- CHAARTED2
Status Notes
This study is open to accrual effective February 8, 2018.
Activated
02/08/2018

Research committees

Genitourinary Cancer

Treatment

Prednisone Abiraterone Acetate Cabazitaxel

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/NRG-GU005
SWOG Clinical Trial Number
S1806

Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer.

Research Committee(s)
Genitourinary Cancer
Activated
04/19/2019
Accrual
22%
Open
Phase
III
SWOG Clinical Trial Number
S1802